Answers are grounded in this paper and cite their sources.
Despite leadership by dedicated lay organization and patient-based advocacy groups, the way forward for prospective candidates for disulfiram treatment has been difficult. This article provides the background, overview of disulfiram, in particular its intended use in post-treatment Lyme disease syndrome after a standard of care course of antibiotics fails to alleviate symptoms of tick borne disease. A series of recommendations are offered to guide patients and clinicians.
No takes yet. Share an insight, caveat, or question.
Younger et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: